Terkafarin sodium

特卡法林钠

Report date: 2023/09/20 20:05:32
NME

Base Information

Drug NameTerkafarin sodium
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVitamin K epOxide reductase complex subunit 1 inhibitors
TargetsVitamin K epOxide reductase complex subunit 1
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesZhaoke Pharmaceutical (Hefei) Co LtdWisdom Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesZhaoke Pharmaceutical (Guangzhou) Co Ltd
Inactive CompaniesWisdom Pharmaceutical Co Ltd
Active IndicationsThrombosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A